Facial and Oral Manifestations Following Covid-19 Vaccination
A Survey-Based Study and a First Perspective
Bibliographic Data
| ID | 15467659 |
|---|---|
| Authors | Marta Mazur (0000-0002-0525-681X, Sapienza University of Rome, corresponding author), Irena Duś‐Ilnicka (0000-0002-4745-2560, Wroclaw Medical University), Maciej Jedliński (0000-0003-3446-6119, Pomeranian Medical University), Artnora Ndokaj (0000-0002-1400-8607, Sapienza University of Rome), Joanna Janiszewska‐Olszowska (0000-0003-4374-2568, Pomeranian Medical University), Roman Ardan (0000-0003-0439-4863, Koszalin University of Technology), Małgorzata Radwan‐Oczko (0000-0003-4684-5722, Wroclaw Medical University), Fabrizio Guerra (0000-0001-8347-0777, Sapienza University of Rome), Valeria Luzzi (0000-0002-2502-6077, Sapienza University of Rome), Iole Vozza (0000-0001-8545-9889, Sapienza University of Rome), Roberto Marasca (0000-0002-6431-6878, Policlinico Umberto I), Livia Ottolenghi (0000-0001-7390-4316, Sapienza University of Rome), Antonella Polimeni (0000-0002-2679-7607, Sapienza University of Rome) |
| Year | 2021 |
| Volume | 18 |
| Issue | 9 |
| Pages | 4965-4965 |
| Publication date | 2021-05-07 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Environmental Research and Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1661-7827 • E-ISSN: 1660-4601 |
| Publisher | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/ijerph18094965 |
| PMID | 34066995 |
| OpenAlex | W3157041091 |
| Language | EN |
| Citations received | 2 |
| References cited | 17 |
(1) Background: Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) emerged in Wuhan, China, in late 2019. The development of effective and safe vaccines against SARS-CoV-2 has been extremely fast. The list of orofacial adverse effects of BNT162b2 and mRNA-1273 vaccines based on the clinical trials are reported to be rare. The aim of this study was to investigate the facial and oral manifestations of COVID-19 vaccination using a survey-based study. (2) Methods: The questionnaire was developed using Google Forms and sent anonymously to a total of 700 subjects (medical personnel) in Poland, Italy, and other EU countries. (3) Results: 223 people answered the questionnaire, mainly vaccinated with BNT162b2. Only 3.1% and 5.4% experienced oral and facial symptoms, respectively. General diseases presence and age have significant influence on the probability of oral symptoms occurrence after the second dose. Facial symptoms are correlated with general disease; autoimmune pathologies and age, at first and second dose, respectively. Gender, smoking and regular medication intake have significant influence on the probability of taking an absence day. Gender, age, and smoking have a significant influence on the duration of symptoms after second dose. (4) Conclusions: Based on the results of this preliminary survey, there is no observed significant correlation between vaccine administration for COVID-19 and facial and oral manifestations
Adverse effect · Coronavirus disease 2019 (COVID-19 · Disease · Infectious disease (medical specialty · Pathology · Tongue · Vaccination · Young adult · Dermatological and COVID-19 studies · Drug-Induced Adverse Reactions · Medicine · SARS-CoV-2 and COVID-19 Research · Immunology · Internal Medicine · Pediatrics
| Unique citing works | 2 |
|---|---|
| Citations per year | 0.4 |
| Citation span | 2021 - 2022 (2) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 2 |